A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaMaria Domenica Cappellini, Antonio Piga, Kevin H.M. Kuo et al.|New England Journal of Medicine|2020Cited by 320
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trialMaria Domenica Cappellini, Alì Taher, Vip Viprakasit et al.|The Lancet Haematology|2025Cited by 17